Related Experiment Video
Updated: Sep 1, 2025

Laparoscopic Common Bile Duct Exploration Followed by Primary Suture Using a Modified Bile Duct Incision
Published on: May 2, 2025
Single-Port Cholecystectomy for Cholecystitis Versus Non-Cholecystitis
Marco Casaccia1, Marta Ponzano2, Tommaso Testa3
1Surgical Clinic Unit I, Department of Surgical Sciences and Integrated Diagnostics (DISC), Genoa University, Genoa, Italy.
Single-port laparoscopic cholecystectomy (SPLC) is a safe and effective treatment for symptomatic cholelithiasis, including acute and chronic cholecystitis. Careful application is advised for acute cases, with further randomized studies needed to confirm reliability.
Area of Science:
- Minimally Invasive Surgery
- Gastrointestinal Surgery
- Surgical Outcomes Research
Background:
- Symptomatic cholelithiasis necessitates effective surgical intervention.
- Single-port laparoscopic cholecystectomy (SPLC) offers a minimally invasive approach.
- Assessing SPLC safety and efficacy across varied gallbladder pathologies is crucial.
Purpose of the Study:
- To evaluate the safety and efficacy of SPLC for symptomatic cholelithiasis.
- To compare SPLC outcomes in patients with normal gallbladder, chronic cholecystitis, and acute cholecystitis.
- To identify predictors of operative time and hospital stay following SPLC.
Main Methods:
- Prospective database registration of 70 patients undergoing SPLC.
- Retrospective chart review and division into normal gallbladder, chronic cholecystitis, and acute cholecystitis groups.
- Analysis of operative time, blood loss, complications, and hospital stay, with statistical comparisons.
Main Results:
- SPLC demonstrated feasibility across gallbladder conditions.
- Operative time significantly increased from normal gallbladder to acute cholecystitis (P=.001).
- Hospital stay was significantly shorter for normal gallbladder patients (P=.020), and pathology type predicted operative time.
Conclusions:
- SPLC is feasible for acute and chronic cholecystitis with good outcomes.
- Caution is advised for SPLC in acute cholecystitis due to potential technical challenges.
- Prospective randomized trials are essential to fully establish SPLC reliability for gallbladder diseases.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...

